APA (7th ed.) Citation

LH, K., J, A., N, B., M, B., AR, D., ZD, D., . . . DR, B. (2023). Once-daily roflumilast foam 0.3% for scalp and body psoriasis: A randomized, double-blind, vehicle-controlled phase IIb study. The British journal of dermatology, 189(4), 392. https://doi.org/10.1093/bjd/ljad182

Chicago Style (17th ed.) Citation

LH, Kircik, et al. "Once-daily Roflumilast Foam 0.3% for Scalp and Body Psoriasis: A Randomized, Double-blind, Vehicle-controlled Phase IIb Study." The British Journal of Dermatology 189, no. 4 (2023): 392. https://doi.org/10.1093/bjd/ljad182.

MLA (9th ed.) Citation

LH, Kircik, et al. "Once-daily Roflumilast Foam 0.3% for Scalp and Body Psoriasis: A Randomized, Double-blind, Vehicle-controlled Phase IIb Study." The British Journal of Dermatology, vol. 189, no. 4, 2023, p. 392, https://doi.org/10.1093/bjd/ljad182.